Learn More
Humans have an incredible capacity to learn properties of objects by pure tactile exploration with their two hands. With robots moving into human-centred environment, tactile exploration becomes more and more important as vision may be occluded easily by obstacles or fail because of different illumination conditions. In this paper, we present our first(More)
Haptic exploration has received a great deal of attention of late thanks to the variety of commercially available tactile sensors. While the majority of previous works consider control of a single contact point at a time, we tackle simultaneous control of multiple contact points on several links. In addition, we use information from the existing tactile(More)
—This paper presents an experiment in which the iCub humanoid robot learns to recognize faces through proprioceptive information. We take inspiration in the way blind people recognize people's faces, i.e. through tactile exploration of the person's face. The iCub robot's tactile sensors are used to provide compliance in the hand motion so as to smoothly(More)
In vitro, EGFR inhibition, combined with the BRAF inhibitor vemurafenib, causes synergistic cytotoxicity for BRAFV600E metastatic colorectal cancer, further augmented by irinotecan. The safety and efficacy of vemurafenib, irinotecan, and cetuximab in BRAF-mutated malignancies are not defined. In this 3+3 phase I study, patients with BRAFV600E-advanced solid(More)
— A stretchable tactile sensor skin has been demonstrated on the dorsal side of a robotic hand for the first time. The sensors can detect normal pressures on the same scale as human skin but also in excess of 250 kPa and withstand strains in excess of 15%. Using tactile information from the sensors mounted on a glove worn by a humanoid robot's hand,(More)
BACKGROUND The present study examined real-world direct health care costs for metastatic colorectal cancer (mCRC) patients initiating first-line (1L) bevacizumab (BEV)- or cetuximab (CET)-containing regimen in 1L or 1L-through-second-line (1L-2L) therapy. PATIENTS AND METHODS Using a large US insurance claims database, patients with mCRC initiating 1L(More)